Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress

The functional crosstalk between angiotensin II (Ang II) and tumor necrosis factor (TNF)-α has been shown to cause adverse left ventricular remodeling and hypertrophy in hypertension. Previous studies from our lab showed that mice lacking TNF-α (TNF-α-/-) have attenuated hypertensive response to Ang...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-09, Vol.10 (9), p.e0138372-e0138372
Hauptverfasser: Sriramula, Srinivas, Francis, Joseph
Format: Artikel
Sprache:eng
Schlagworte:
RNA
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0138372
container_issue 9
container_start_page e0138372
container_title PloS one
container_volume 10
creator Sriramula, Srinivas
Francis, Joseph
description The functional crosstalk between angiotensin II (Ang II) and tumor necrosis factor (TNF)-α has been shown to cause adverse left ventricular remodeling and hypertrophy in hypertension. Previous studies from our lab showed that mice lacking TNF-α (TNF-α-/-) have attenuated hypertensive response to Ang II; however, the signaling mechanisms involved are not known. In this study, we investigated the signaling pathways involved in the Ang II and TNF-α interaction. Chronic Ang II infusion (1 μg/kg/min, 14 days) significantly increased cardiac collagen I, collagen III, CTGF and TGF-β mRNA and protein expression in wild-type (WT) mice, whereas these changes were decreased in TNF-α-/- mice. TNF-α-/- mice with Ang II infusion showed reduced myocardial perivascular and interstitial fibrosis compared to WT mice with Ang II infusion. In WT mice, Ang II infusion increased reactive oxygen species formation and the expression of NADPH oxidase subunits, indicating increased oxidative stress, but not in TNF-α-/- mice. In addition, treatment with etanercept (8 mg/kg, every 3 days) for two weeks blunted the Ang II-induced hypertension (133 ± 4 vs 154 ± 3 mmHg, p
doi_str_mv 10.1371/journal.pone.0138372
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1719287222</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A428957881</galeid><doaj_id>oai_doaj_org_article_d1d8cb76966f4ded81649cdd99da5d66</doaj_id><sourcerecordid>A428957881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c758t-6b6cb372244dbb79d1a48534b02618b7b9f5ff7fe17293b44be76aac0dd911f13</originalsourceid><addsrcrecordid>eNqNk1Fv1SAUxxujcXP6DYw2MTH60GtpKVAfTG6WTZss3uRu7pVQoL0sFO6gnfPbS-_tlluzB9MHCvz-_8M5cKLoLUgXIMfgy40dnGF6sbVGLlKQkxxnz6JjUOZZgrI0f37wfxS98v4mTYucIPQyOspQjgku0-Po99XQWRf_lNxZr3x8zngf5km81NsNiysfn3kvTa-YjpuwsTStsr00Xpm4qpLKiIFLEV8HxCk-aObiteyskFqZ9mu8tlrudKt7JViv7mR82Tvp_evoRcO0l2-m8ST6dX52dfojuVh9r06XFwnHBekTVCNeh8QyCEVd41IABkmRwzrNECA1rsumaBrcSICzMq8hrCVGjPFUiBKABuQn0fu971ZbT6eaeQowKDMSfLNAVHtCWHZDt051zP2hlim6W7Cupcz1imtJBRCE1xiVCDVQSEEAgiUPoUrBCoFQ8Po2RRvqTgo-VoXpmel8x6gNbe0dhQWGOB2P-2kycPZ2kL6nnfJcas2MtMPu3HkJIQFpQD_8gz6d3US1LCSgTGNDXD6a0iXMSFlgQsawiyeo8AnZKR4eWKPC-kzweSYITC_v-5YN3tPqcv3_7Op6zn48YDeS6X7jrR56ZY2fg3APju_WO9k8FhmkdOyPh2rQsT_o1B9B9u7wgh5FDw2R_wVieAtK</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1719287222</pqid></control><display><type>article</type><title>Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Sriramula, Srinivas ; Francis, Joseph</creator><creatorcontrib>Sriramula, Srinivas ; Francis, Joseph</creatorcontrib><description>The functional crosstalk between angiotensin II (Ang II) and tumor necrosis factor (TNF)-α has been shown to cause adverse left ventricular remodeling and hypertrophy in hypertension. Previous studies from our lab showed that mice lacking TNF-α (TNF-α-/-) have attenuated hypertensive response to Ang II; however, the signaling mechanisms involved are not known. In this study, we investigated the signaling pathways involved in the Ang II and TNF-α interaction. Chronic Ang II infusion (1 μg/kg/min, 14 days) significantly increased cardiac collagen I, collagen III, CTGF and TGF-β mRNA and protein expression in wild-type (WT) mice, whereas these changes were decreased in TNF-α-/- mice. TNF-α-/- mice with Ang II infusion showed reduced myocardial perivascular and interstitial fibrosis compared to WT mice with Ang II infusion. In WT mice, Ang II infusion increased reactive oxygen species formation and the expression of NADPH oxidase subunits, indicating increased oxidative stress, but not in TNF-α-/- mice. In addition, treatment with etanercept (8 mg/kg, every 3 days) for two weeks blunted the Ang II-induced hypertension (133 ± 4 vs 154 ± 3 mmHg, p&lt;0.05) and cardiac hypertrophy (heart weight to body weight ratio, 4.8 ± 0.2 vs 5.6 ± 0.3, p&lt;0.05) in WT mice. Furthermore, Ang II-induced activation of NF-κB, p38 MAPK, and JNK were reduced in both TNF-α-/- mice and mice treated with etanercept. Together, these findings indicate that TNF-α contributes to Ang II-induced hypertension and adverse cardiac remodeling, and that these effects are associated with changes in the oxidative stress dependent MAPK/TGF-β/NF-κB pathway. These results may provide new insight into the mechanisms of Ang II and TNF-α interaction.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0138372</identifier><identifier>PMID: 26378790</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Angiotensin ; Angiotensin II ; Angiotensin II - pharmacology ; Angiotensins ; Animals ; Blood pressure ; Blood Pressure - drug effects ; Blood Pressure - physiology ; Body weight ; Bone morphogenetic proteins ; Cardiomegaly - metabolism ; Collagen ; Collagen (type I) ; Collagen (type III) ; Collagen Type I - metabolism ; Collagen Type III - metabolism ; Collagens ; Connective tissue growth factor ; Connective Tissue Growth Factor - metabolism ; Crosstalk ; Etanercept ; Fibrosis ; Fibrosis - metabolism ; Fibrosis - pathology ; Gene expression ; Heart ; Heart - drug effects ; Heart - physiopathology ; Heart diseases ; Heart hypertrophy ; Hypertension ; Hypertension - metabolism ; Hypertension - physiopathology ; Hypertrophy ; Infusion ; JNK protein ; Kinases ; Male ; MAP kinase ; MAP Kinase Signaling System - drug effects ; MAP Kinase Signaling System - physiology ; Mice ; mRNA ; Myocardium - metabolism ; NAD(P)H oxidase ; NADPH Oxidases - metabolism ; Necrosis ; NF-kappa B - metabolism ; NF-κB protein ; Nitric oxide ; Oxidases ; Oxidative stress ; Oxidative Stress - drug effects ; Oxidative Stress - physiology ; Oxygen ; p38 Mitogen-Activated Protein Kinases - metabolism ; Reactive oxygen species ; Receptor, Angiotensin, Type 1 - metabolism ; RNA ; RNA, Messenger - metabolism ; Signal transduction ; Signal Transduction - drug effects ; Signal Transduction - physiology ; Signaling ; Transforming Growth Factor beta - metabolism ; Transforming growth factors ; Tumor necrosis factor ; Tumor Necrosis Factor-alpha - metabolism ; Tumor necrosis factor-TNF ; Tumor necrosis factor-α ; Tumors ; Ventricle ; Ventricular Remodeling - drug effects ; Ventricular Remodeling - physiology ; Veterinary colleges</subject><ispartof>PloS one, 2015-09, Vol.10 (9), p.e0138372-e0138372</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Sriramula, Francis. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Sriramula, Francis 2015 Sriramula, Francis</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c758t-6b6cb372244dbb79d1a48534b02618b7b9f5ff7fe17293b44be76aac0dd911f13</citedby><cites>FETCH-LOGICAL-c758t-6b6cb372244dbb79d1a48534b02618b7b9f5ff7fe17293b44be76aac0dd911f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574701/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574701/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79569,79570</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26378790$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sriramula, Srinivas</creatorcontrib><creatorcontrib>Francis, Joseph</creatorcontrib><title>Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The functional crosstalk between angiotensin II (Ang II) and tumor necrosis factor (TNF)-α has been shown to cause adverse left ventricular remodeling and hypertrophy in hypertension. Previous studies from our lab showed that mice lacking TNF-α (TNF-α-/-) have attenuated hypertensive response to Ang II; however, the signaling mechanisms involved are not known. In this study, we investigated the signaling pathways involved in the Ang II and TNF-α interaction. Chronic Ang II infusion (1 μg/kg/min, 14 days) significantly increased cardiac collagen I, collagen III, CTGF and TGF-β mRNA and protein expression in wild-type (WT) mice, whereas these changes were decreased in TNF-α-/- mice. TNF-α-/- mice with Ang II infusion showed reduced myocardial perivascular and interstitial fibrosis compared to WT mice with Ang II infusion. In WT mice, Ang II infusion increased reactive oxygen species formation and the expression of NADPH oxidase subunits, indicating increased oxidative stress, but not in TNF-α-/- mice. In addition, treatment with etanercept (8 mg/kg, every 3 days) for two weeks blunted the Ang II-induced hypertension (133 ± 4 vs 154 ± 3 mmHg, p&lt;0.05) and cardiac hypertrophy (heart weight to body weight ratio, 4.8 ± 0.2 vs 5.6 ± 0.3, p&lt;0.05) in WT mice. Furthermore, Ang II-induced activation of NF-κB, p38 MAPK, and JNK were reduced in both TNF-α-/- mice and mice treated with etanercept. Together, these findings indicate that TNF-α contributes to Ang II-induced hypertension and adverse cardiac remodeling, and that these effects are associated with changes in the oxidative stress dependent MAPK/TGF-β/NF-κB pathway. These results may provide new insight into the mechanisms of Ang II and TNF-α interaction.</description><subject>Angiotensin</subject><subject>Angiotensin II</subject><subject>Angiotensin II - pharmacology</subject><subject>Angiotensins</subject><subject>Animals</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure - physiology</subject><subject>Body weight</subject><subject>Bone morphogenetic proteins</subject><subject>Cardiomegaly - metabolism</subject><subject>Collagen</subject><subject>Collagen (type I)</subject><subject>Collagen (type III)</subject><subject>Collagen Type I - metabolism</subject><subject>Collagen Type III - metabolism</subject><subject>Collagens</subject><subject>Connective tissue growth factor</subject><subject>Connective Tissue Growth Factor - metabolism</subject><subject>Crosstalk</subject><subject>Etanercept</subject><subject>Fibrosis</subject><subject>Fibrosis - metabolism</subject><subject>Fibrosis - pathology</subject><subject>Gene expression</subject><subject>Heart</subject><subject>Heart - drug effects</subject><subject>Heart - physiopathology</subject><subject>Heart diseases</subject><subject>Heart hypertrophy</subject><subject>Hypertension</subject><subject>Hypertension - metabolism</subject><subject>Hypertension - physiopathology</subject><subject>Hypertrophy</subject><subject>Infusion</subject><subject>JNK protein</subject><subject>Kinases</subject><subject>Male</subject><subject>MAP kinase</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>MAP Kinase Signaling System - physiology</subject><subject>Mice</subject><subject>mRNA</subject><subject>Myocardium - metabolism</subject><subject>NAD(P)H oxidase</subject><subject>NADPH Oxidases - metabolism</subject><subject>Necrosis</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB protein</subject><subject>Nitric oxide</subject><subject>Oxidases</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - physiology</subject><subject>Oxygen</subject><subject>p38 Mitogen-Activated Protein Kinases - metabolism</subject><subject>Reactive oxygen species</subject><subject>Receptor, Angiotensin, Type 1 - metabolism</subject><subject>RNA</subject><subject>RNA, Messenger - metabolism</subject><subject>Signal transduction</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><subject>Signaling</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Transforming growth factors</subject><subject>Tumor necrosis factor</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumor necrosis factor-α</subject><subject>Tumors</subject><subject>Ventricle</subject><subject>Ventricular Remodeling - drug effects</subject><subject>Ventricular Remodeling - physiology</subject><subject>Veterinary colleges</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1Fv1SAUxxujcXP6DYw2MTH60GtpKVAfTG6WTZss3uRu7pVQoL0sFO6gnfPbS-_tlluzB9MHCvz-_8M5cKLoLUgXIMfgy40dnGF6sbVGLlKQkxxnz6JjUOZZgrI0f37wfxS98v4mTYucIPQyOspQjgku0-Po99XQWRf_lNxZr3x8zngf5km81NsNiysfn3kvTa-YjpuwsTStsr00Xpm4qpLKiIFLEV8HxCk-aObiteyskFqZ9mu8tlrudKt7JViv7mR82Tvp_evoRcO0l2-m8ST6dX52dfojuVh9r06XFwnHBekTVCNeh8QyCEVd41IABkmRwzrNECA1rsumaBrcSICzMq8hrCVGjPFUiBKABuQn0fu971ZbT6eaeQowKDMSfLNAVHtCWHZDt051zP2hlim6W7Cupcz1imtJBRCE1xiVCDVQSEEAgiUPoUrBCoFQ8Po2RRvqTgo-VoXpmel8x6gNbe0dhQWGOB2P-2kycPZ2kL6nnfJcas2MtMPu3HkJIQFpQD_8gz6d3US1LCSgTGNDXD6a0iXMSFlgQsawiyeo8AnZKR4eWKPC-kzweSYITC_v-5YN3tPqcv3_7Op6zn48YDeS6X7jrR56ZY2fg3APju_WO9k8FhmkdOyPh2rQsT_o1B9B9u7wgh5FDw2R_wVieAtK</recordid><startdate>20150917</startdate><enddate>20150917</enddate><creator>Sriramula, Srinivas</creator><creator>Francis, Joseph</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150917</creationdate><title>Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress</title><author>Sriramula, Srinivas ; Francis, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c758t-6b6cb372244dbb79d1a48534b02618b7b9f5ff7fe17293b44be76aac0dd911f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Angiotensin</topic><topic>Angiotensin II</topic><topic>Angiotensin II - pharmacology</topic><topic>Angiotensins</topic><topic>Animals</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure - physiology</topic><topic>Body weight</topic><topic>Bone morphogenetic proteins</topic><topic>Cardiomegaly - metabolism</topic><topic>Collagen</topic><topic>Collagen (type I)</topic><topic>Collagen (type III)</topic><topic>Collagen Type I - metabolism</topic><topic>Collagen Type III - metabolism</topic><topic>Collagens</topic><topic>Connective tissue growth factor</topic><topic>Connective Tissue Growth Factor - metabolism</topic><topic>Crosstalk</topic><topic>Etanercept</topic><topic>Fibrosis</topic><topic>Fibrosis - metabolism</topic><topic>Fibrosis - pathology</topic><topic>Gene expression</topic><topic>Heart</topic><topic>Heart - drug effects</topic><topic>Heart - physiopathology</topic><topic>Heart diseases</topic><topic>Heart hypertrophy</topic><topic>Hypertension</topic><topic>Hypertension - metabolism</topic><topic>Hypertension - physiopathology</topic><topic>Hypertrophy</topic><topic>Infusion</topic><topic>JNK protein</topic><topic>Kinases</topic><topic>Male</topic><topic>MAP kinase</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>MAP Kinase Signaling System - physiology</topic><topic>Mice</topic><topic>mRNA</topic><topic>Myocardium - metabolism</topic><topic>NAD(P)H oxidase</topic><topic>NADPH Oxidases - metabolism</topic><topic>Necrosis</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB protein</topic><topic>Nitric oxide</topic><topic>Oxidases</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - physiology</topic><topic>Oxygen</topic><topic>p38 Mitogen-Activated Protein Kinases - metabolism</topic><topic>Reactive oxygen species</topic><topic>Receptor, Angiotensin, Type 1 - metabolism</topic><topic>RNA</topic><topic>RNA, Messenger - metabolism</topic><topic>Signal transduction</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><topic>Signaling</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Transforming growth factors</topic><topic>Tumor necrosis factor</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumor necrosis factor-α</topic><topic>Tumors</topic><topic>Ventricle</topic><topic>Ventricular Remodeling - drug effects</topic><topic>Ventricular Remodeling - physiology</topic><topic>Veterinary colleges</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sriramula, Srinivas</creatorcontrib><creatorcontrib>Francis, Joseph</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale in Context : Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sriramula, Srinivas</au><au>Francis, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-09-17</date><risdate>2015</risdate><volume>10</volume><issue>9</issue><spage>e0138372</spage><epage>e0138372</epage><pages>e0138372-e0138372</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The functional crosstalk between angiotensin II (Ang II) and tumor necrosis factor (TNF)-α has been shown to cause adverse left ventricular remodeling and hypertrophy in hypertension. Previous studies from our lab showed that mice lacking TNF-α (TNF-α-/-) have attenuated hypertensive response to Ang II; however, the signaling mechanisms involved are not known. In this study, we investigated the signaling pathways involved in the Ang II and TNF-α interaction. Chronic Ang II infusion (1 μg/kg/min, 14 days) significantly increased cardiac collagen I, collagen III, CTGF and TGF-β mRNA and protein expression in wild-type (WT) mice, whereas these changes were decreased in TNF-α-/- mice. TNF-α-/- mice with Ang II infusion showed reduced myocardial perivascular and interstitial fibrosis compared to WT mice with Ang II infusion. In WT mice, Ang II infusion increased reactive oxygen species formation and the expression of NADPH oxidase subunits, indicating increased oxidative stress, but not in TNF-α-/- mice. In addition, treatment with etanercept (8 mg/kg, every 3 days) for two weeks blunted the Ang II-induced hypertension (133 ± 4 vs 154 ± 3 mmHg, p&lt;0.05) and cardiac hypertrophy (heart weight to body weight ratio, 4.8 ± 0.2 vs 5.6 ± 0.3, p&lt;0.05) in WT mice. Furthermore, Ang II-induced activation of NF-κB, p38 MAPK, and JNK were reduced in both TNF-α-/- mice and mice treated with etanercept. Together, these findings indicate that TNF-α contributes to Ang II-induced hypertension and adverse cardiac remodeling, and that these effects are associated with changes in the oxidative stress dependent MAPK/TGF-β/NF-κB pathway. These results may provide new insight into the mechanisms of Ang II and TNF-α interaction.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>26378790</pmid><doi>10.1371/journal.pone.0138372</doi><tpages>e0138372</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2015-09, Vol.10 (9), p.e0138372-e0138372
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1719287222
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Angiotensin
Angiotensin II
Angiotensin II - pharmacology
Angiotensins
Animals
Blood pressure
Blood Pressure - drug effects
Blood Pressure - physiology
Body weight
Bone morphogenetic proteins
Cardiomegaly - metabolism
Collagen
Collagen (type I)
Collagen (type III)
Collagen Type I - metabolism
Collagen Type III - metabolism
Collagens
Connective tissue growth factor
Connective Tissue Growth Factor - metabolism
Crosstalk
Etanercept
Fibrosis
Fibrosis - metabolism
Fibrosis - pathology
Gene expression
Heart
Heart - drug effects
Heart - physiopathology
Heart diseases
Heart hypertrophy
Hypertension
Hypertension - metabolism
Hypertension - physiopathology
Hypertrophy
Infusion
JNK protein
Kinases
Male
MAP kinase
MAP Kinase Signaling System - drug effects
MAP Kinase Signaling System - physiology
Mice
mRNA
Myocardium - metabolism
NAD(P)H oxidase
NADPH Oxidases - metabolism
Necrosis
NF-kappa B - metabolism
NF-κB protein
Nitric oxide
Oxidases
Oxidative stress
Oxidative Stress - drug effects
Oxidative Stress - physiology
Oxygen
p38 Mitogen-Activated Protein Kinases - metabolism
Reactive oxygen species
Receptor, Angiotensin, Type 1 - metabolism
RNA
RNA, Messenger - metabolism
Signal transduction
Signal Transduction - drug effects
Signal Transduction - physiology
Signaling
Transforming Growth Factor beta - metabolism
Transforming growth factors
Tumor necrosis factor
Tumor Necrosis Factor-alpha - metabolism
Tumor necrosis factor-TNF
Tumor necrosis factor-α
Tumors
Ventricle
Ventricular Remodeling - drug effects
Ventricular Remodeling - physiology
Veterinary colleges
title Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T22%3A42%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20Necrosis%20Factor%20-%20Alpha%20Is%20Essential%20for%20Angiotensin%20II-Induced%20Ventricular%20Remodeling:%20Role%20for%20Oxidative%20Stress&rft.jtitle=PloS%20one&rft.au=Sriramula,%20Srinivas&rft.date=2015-09-17&rft.volume=10&rft.issue=9&rft.spage=e0138372&rft.epage=e0138372&rft.pages=e0138372-e0138372&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0138372&rft_dat=%3Cgale_plos_%3EA428957881%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1719287222&rft_id=info:pmid/26378790&rft_galeid=A428957881&rft_doaj_id=oai_doaj_org_article_d1d8cb76966f4ded81649cdd99da5d66&rfr_iscdi=true